| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/25/2002 | US20020049183 Phospholipids, espeically phosphatidylethanolamines, covalently bound to physiologically acceptable monomers or polymers. |
| 04/25/2002 | US20020049180 KIAA0175 inhibitor is selected from the group consisting of an anti-sense molecule, a ribozyme, an antibody, an antibody fragment, a protein, a polypeptide and a small molecule. |
| 04/25/2002 | US20020049174 First region is available for hybridization and the second region is temporarily masked. |
| 04/25/2002 | US20020049170 Method for reducing toxicity of combined chemotherapies |
| 04/25/2002 | US20020049169 Administration of 7-methylthiomethyl taxol and doxorubicin |
| 04/25/2002 | US20020049166 Antineoplastic agents and antioxidants; preservative and topiosomerase-inhibiting compositions |
| 04/25/2002 | US20020049158 Increasing bioavailability of a drug which is not readily absorbed in the digestive tract |
| 04/25/2002 | US20020049154 Bioconjugates and delivery of bioactive agents |
| 04/25/2002 | US20020048801 Peptide with enzymatic activity; for use as diagnostic tools in detecting cancer and cardiovascular and liver disorders |
| 04/25/2002 | US20020048794 Polypeptides for use in the diagnosis and treatment of skin disorders, cancer, vision and demyelination defects, inflammation, glomerculonephritis, Kaposi's sarcoma, angiogenesis, sarcoidosis, osteoarthritis and aneurysm |
| 04/25/2002 | US20020048786 Nucleotide sequences for use in the treatment of infections, arthritis, karposi's sarcoma, allergies, asthma, nervous system and autoimmune diseases |
| 04/25/2002 | US20020048777 Nucleotide sequences for use in therapy, monitoring and screning preferential tumors |
| 04/25/2002 | US20020048587 Containing an antigen or at least one in vivo generator of a compound comprising an amino acid sequence. |
| 04/25/2002 | US20020048583 Combining ex vivo an antigen and an antigen-presenting cell binding agent specific for the antigen, and administering the composition to a patient suffering from a disease associated with the antigen |
| 04/25/2002 | US20020048579 Treated tissue or organ can be transplanted in a recipient with reduced risk of graft-versus-host disease. |
| 04/25/2002 | US20020048571 Chimeric polypeptides of serum albumin and uses related thereto |
| 04/25/2002 | US20020048570 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/25/2002 | US20020048569 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/25/2002 | US20020048568 Plant extract veterinary feed additive; food additive for enhancing weight gain in a recipient; Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799). |
| 04/25/2002 | US20020048567 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/25/2002 | US20020048271 Methods and composition for restoring conformational stability of a protein of the p53 family |
| 04/25/2002 | DE10051321A1 New 2-(4-amino-piperidin-1-yl)-2-aryl-N-(phenylalkyl)-acetamides, are potent neurokinin antagonists, useful e.g. for treating allergic, inflammatory or central nervous system diseases |
| 04/25/2002 | DE10051320A1 New 2-(4-amino-piperidin-1-yl)-2-aryl-N-(phenylalkyl)-acetamides, are neurokinin antagonists having a long duration of action, useful e.g. for treating allergic, inflammatory or central nervous system diseases |
| 04/25/2002 | DE10050334A1 Composition comprising stem cells and CD6-depleted stem cells, useful for inducing transplant tolerance and for treatment, especially of leukemia, administered separately |
| 04/25/2002 | DE10050236A1 Use of specified compounds as sigma-receptor ligands, useful for treating carcinomas and sarcomas |
| 04/25/2002 | DE10034673C1 Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung Dermal application system for aminolevulinic acid and its use |
| 04/25/2002 | CA2818654A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2464121A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | CA2426366A1 Fusion cells and cytokine compositions for treatment of disease |
| 04/25/2002 | CA2426271A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 04/25/2002 | CA2426103A1 New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents |
| 04/25/2002 | CA2425963A1 Human kinases |
| 04/25/2002 | CA2425900A1 Novel medicinal herbal composition for treating liver diseases and hiv |
| 04/25/2002 | CA2425727A1 Methods and compositions for promoting the maturation of monocytes |
| 04/25/2002 | CA2425605A1 Nucleic acid ligands to the prostate specific membrane antigen |
| 04/25/2002 | CA2425196A1 A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes |
| 04/25/2002 | CA2424729A1 Estrogen receptor modulators |
| 04/25/2002 | CA2424726A1 Estrogen receptor modulators |
| 04/25/2002 | CA2424689A1 Orally active salts with tyrosine kinase activity |
| 04/25/2002 | CA2424345A1 Liposomal formulation of mitoxantrone |
| 04/25/2002 | CA2423789A1 Bridged piperazine derivatives |
| 04/25/2002 | CA2423599A1 Methods of producing oxazolidinone compounds |
| 04/25/2002 | CA2423013A1 Use of inhibitors of progesteron receptor for treating cancer |
| 04/24/2002 | EP1199372A2 Polymorphisms in the human P2X7 gene |
| 04/24/2002 | EP1199368A2 Use of adenoviral e4 reading frames to improve expression of a gene of interest |
| 04/24/2002 | EP1199361A2 Glycoprotein hormone receptor molecules. Their uses |
| 04/24/2002 | EP1199358A1 Gene encoding promoter domain of tumor suppressor gene p51 and use thereof |
| 04/24/2002 | EP1199307A1 Pharmaceutically active benzoquinazoline compounds |
| 04/24/2002 | EP1199306A1 Biarylurea derivatives |
| 04/24/2002 | EP1199074A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 04/24/2002 | EP1199071A2 Use of an estrogen agonist/antagonist for improving vascular health |
| 04/24/2002 | EP1199067A2 Prophylactic use of N-Methyl-D-Aspartate (NMDA) antagonists |
| 04/24/2002 | EP1198589A1 Tenascin-c nucleic acid ligands |
| 04/24/2002 | EP1198563A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 04/24/2002 | EP1198560A2 Mammalian adhesion protease peptides |
| 04/24/2002 | EP1198479A1 Neovascular-targeted immunoconjugates |
| 04/24/2002 | EP1198478A1 Somatostatin analogs and their use for the treatment of cancer |
| 04/24/2002 | EP1198475A1 Highly purified cytokine activating factor and methods of use |
| 04/24/2002 | EP1198467A1 5-nitrofurfural derivatives |
| 04/24/2002 | EP1198458A2 Ceramide analogs, process for their preparation and their use as antitumor agents |
| 04/24/2002 | EP1198256A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 04/24/2002 | EP1198255A1 Identification of compounds that modify transcriptional responses to hypoxia |
| 04/24/2002 | EP1198254A2 Carrier-drug conjugate |
| 04/24/2002 | EP1198253A2 Biologically active materials |
| 04/24/2002 | EP1198252A1 Radioenhanced cancer treatment using orally administered camptothecin derivatives |
| 04/24/2002 | EP1198251A1 Combination of an anti-ep-cam antibody with a chemotherapeutic agent |
| 04/24/2002 | EP1198247A2 Compositions and methods related to claudin-7 |
| 04/24/2002 | EP1198246A2 Methods for preventing or attenuating pathoangiogenic conditions by using the gbs-toxin (cm101) receptor as a vaccine |
| 04/24/2002 | EP1198241A1 Novel proteins |
| 04/24/2002 | EP1198239A1 Methods employing bacterial toxin-antitoxin systems for killing eukaryotic cells |
| 04/24/2002 | EP1198233A1 Sulfonamide and sulfamide substituted imidazoquinolines |
| 04/24/2002 | EP1198232A1 Urea substituted imidazoquinolines |
| 04/24/2002 | EP1198231A1 Bicyclic antagonists selective for the(alpha)v(beta)3 integrin |
| 04/24/2002 | EP0863911B1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 04/24/2002 | EP0788388B1 Device for aerosolized delivery of peptide drugs |
| 04/24/2002 | EP0785951B1 Tc or re radiolabelled somatostatin analogs |
| 04/24/2002 | EP0714298B1 Photosensitiser containing phthalocyanine derivative for photodynamic therapy of tumours |
| 04/24/2002 | CN1346406A Human ubiquitin ligase E3 for the modulation of NF-kappa 8 |
| 04/24/2002 | CN1346371A Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 04/24/2002 | CN1346370A Polypeptides involved in immune response |
| 04/24/2002 | CN1346364A 16-hydroxyestratrienes as selective estrogens |
| 04/24/2002 | CN1346363A The novel antisense-oligos with better stability and antisense effect |
| 04/24/2002 | CN1346355A Novel inhibitors of farnesyl-protein transferase |
| 04/24/2002 | CN1346353A Farnesy transferase inhibitors having a pyrrole structure and process for preparation thereof |
| 04/24/2002 | CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4 |
| 04/24/2002 | CN1346284A CD 40 binding molecules and CTL peptides for treating tumors |
| 04/24/2002 | CN1346282A Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as combination therapy method in treating neoplasia |
| 04/24/2002 | CN1346279A Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| 04/24/2002 | CN1346277A Use of a serenoa repens extract for the production of a medicament to treat prostate cancer |
| 04/24/2002 | CN1346275A Treatment of accidental extravasation of anthracyclines |
| 04/24/2002 | CN1346272A Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 04/24/2002 | CN1346271A Quinazoline derivatives as angiogenesis inhibitors |
| 04/24/2002 | CN1346269A Calcilytic compounds |
| 04/24/2002 | CN1345728A Solasodine hydrochlorate and productive method and application in medicine |
| 04/24/2002 | CN1345594A Traditional Chinese medicine for treating hymph tumor and breast tumor |
| 04/24/2002 | CN1083453C Fused imidazole derivatives as emultidrug resistance modulators |
| 04/24/2002 | CN1083452C Pyrido (2,3-d) pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation |
| 04/24/2002 | CN1083275C Medicine for treating breast tuomor and carbuncle and preparation method thereof |
| 04/24/2002 | CN1083269C Chinese herbal medicine for treating hysteromyoma and breast fibrosarcoma and its prepn. method |